Breast cancer: present and future

Áreas de cooperación: 
Persona de contacto: 
Cristina Núñez González
Hospital Universitario Lucus Augusti
Rúa Ulises Romero Nº1
Código Postal: 
Palabras clave: 
breast cancer, luminal A, luminal B, HER2-positive, and triple negative
Descripción del proyecto: 
Breast cancer (BC) is the most commonly diagnosed cancer in women worldwide. Today, even though major breast cancer subtypes have been characterized, i.e., luminal A, luminal B, HER2-positive, and triple negative, little is known about the heterogeneity of breast cancer in blood. In particular, phosphoproteins secreted or shed by cancer cells constitute a largely overlooked source of biomarker candidates that could be correlated with breast cancer subtypes and/or disease status.
Objetivos principales: 
The main objective of this proposal is discovering minimally invasive protein biomarkers in blood for the early noninvasive diagnosis, classification and monitorization of different breast cancer subtypes. These new blood-based biomarkers that are highly specific could offer the potential to decrease BC morbidity as well as identify the most appropriate treatment options.


Seleccione abajo para suscribirse

Capitalisation: Interact Thematic networks

POCTEP Contacts

Contacts 2014-2020 | Contacts 2007-2013

  • (+34) 924 20 59 58
  • C/ Luís Álvarez Lencero 3, Planta 3ª, Of. 13, 06011 BADAJOZ (Spain)